Hepion Pharmaceuticals In... (HEPA)
0.45
-0.02 (-5.26%)
At close: Jan 15, 2025, 12:21 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -48.93M | -42.20M | -32.72M | -20.35M | -7.04M | -9.45M | -15.02M | -14.89M | -17.00M | -14.35M | -5.28M | -842.97 |
| Depreciation & Amortization | 67.13K | 77.46K | 86.07K | 34.52K | 26.74K | 18.79K | 21.94K | 27.99K | 21.52K | 16.36K | 1.32K | n/a |
| Stock-Based Compensation | 1.34M | 2.55M | 4.67M | 2.38M | 66.18K | 234.51K | 1.57K | 1.70M | 901.87K | 2.12M | 195.23K | n/a |
| Other Working Capital | 2.67M | 907.03K | -4.50M | -1.41M | -509.19K | -970.48K | 91.99K | n/a | 3.33M | 952.88K | -168.62 | n/a |
| Other Non-Cash Items | 4.07M | -414.99K | 2.31M | 140.00K | 157.28K | -4.94M | 7.34M | -4.17M | -3.81M | 1.59M | 3.60M | 763.27 |
| Deferred Income Tax | -409.02K | 1.87M | n/a | 6.05K | 48.32K | -536.00K | -372.92K | -4.22M | n/a | 387.90K | n/a | n/a |
| Change in Working Capital | 2.97M | 3.15M | -5.57M | 1.63M | -826.23K | -970.48K | -19.21K | -1.84M | 3.33M | 952.88K | 125.43K | n/a |
| Operating Cash Flow | -40.89M | -34.96M | -31.22M | -16.17M | -7.57M | -15.65M | -8.21M | -19.17M | -16.56M | -9.67M | -1.36M | -79.7 |
| Capital Expenditures | -14.30K | -16.34K | -130.41K | -87.98K | -51.47K | n/a | -2.43 | -14.71K | -6.60K | -83.27K | -15.85K | n/a |
| Acquisitions | n/a | 2.27K | n/a | 2.19K | n/a | 900.00 | n/a | n/a | -495.60K | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 2.27 | n/a | 2.19 | n/a | 0.90 | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -14.30K | -14.07K | -130.41K | -85.79K | -51.47K | 900.00 | -2.43 | -14.71K | -502.21K | -83.27K | -15.85K | n/a |
| Debt Repayment | n/a | n/a | -176.59K | 176.59K | -1.12M | 1.33M | n/a | -10.41K | n/a | n/a | -100.00K | n/a |
| Common Stock Repurchased | n/a | -21.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.49M | -5.14M | n/a | 12.00K | 12.14M | 9.56M | 11.90M | 116.28K | 19.90M | 12.50M | -15.03K | 600.00 |
| Financial Cash Flow | 4.49M | -5.14M | 81.98M | 43.05M | 18.71M | 12.52M | 1.18M | 24.77M | 19.90M | 12.50M | 3.11M | 600.00 |
| Net Cash Flow | -36.40M | -40.16M | 50.62M | 26.80M | 11.09M | -3.12M | -1.45M | 5.58M | 2.84M | 2.75M | 1.73M | 520.30 |
| Free Cash Flow | -40.90M | -34.98M | -31.35M | -16.25M | -7.62M | -15.65M | -8.21M | -19.19M | -16.56M | -9.76M | -1.38M | -79.7 |